01 9Gowling WLG (Canada) LLP
01 32491632
02 32614334
03 32615669
01 3NILOTINIB HYDROCHLORIDE MONOHYDRATE
02 6Nilotinib hydrochloride monohydrate
01 3CAPSULE
02 6Capsule
01 32023-07-04
02 62026-07-18
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Brand Name : TASIGNA
Patent Number : 2491632
Filing Date : 2003-07-04
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Brand Name : TASIGNA
Patent Number : 2491632
Filing Date : 2003-07-04
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Brand Name : TASIGNA
Patent Number : 2615669
Filing Date : 2006-07-18
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Brand Name : TASIGNA
Patent Number : 2614334
Filing Date : 2006-07-18
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Brand Name : TASIGNA
Patent Number : 2615669
Filing Date : 2006-07-18
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Brand Name : TASIGNA
Patent Number : 2614334
Filing Date : 2006-07-18
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Brand Name : TASIGNA
Patent Number : 2614334
Filing Date : 2006-07-18
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-07-18
Date Granted : 2015-04-21
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Brand Name : TASIGNA
Patent Number : 2615669
Filing Date : 2006-07-18
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-07-18
Date Granted : 2013-11-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Brand Name : TASIGNA
Patent Number : 2491632
Filing Date : 2003-07-04
Strength per Unit : 50 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2023-07-04
Date Granted : 2009-11-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
